J G Cleland|K Swedberg - JoVE Visualize

Showing results (241-250 of 297) with videos related to

Pageof 30

Sort By:

Journal of Internal Medicine. Supplement|January 1, 1991

Prehospital thrombolysis in suspected acute myocardial infarction: results from the TEAHAT StudyM Risenfors, G Gustavsson, L Ekström, et al.

Journal of Internal Medicine. Supplement|January 1, 1991

Mortality and morbidity 1 year after early thrombolysis in suspected AMI: results from the TEAHAT StudyJ Herlitz, M Dellborg, M Hartford, et al.

European Heart Journal|December 1, 1994

Elevated plasma endothelin concentrations in heart failure; an effect of angiotensin II?J M Good, P Nihoyannopoulos, M A Ghatei, et al.

Cardiovascular Research|December 23, 1998

Endothelin-1 has haemodynamic effects at pathophysiological concentrations in patients with left ventricular dysfunctionP J Cowburn, J G Cleland, J D McArthur, et al.

Journal of the American College of Cardiology|March 26, 1999

Endothelin B receptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunctionP J Cowburn, J G Cleland, J D McArthur, et al.

Cardiovascular Drugs and Therapy|October 12, 1999

Effects of the Ikr-blocker almokalant and predictors of conversion of chronic atrial tachyarrhythmias to sinus rhythm. A prospective studyB Houltz, B Darpö, K Swedberg, et al.

American Heart Journal|May 27, 2003

Prognostic importance of the oxidized product of catecholamines, adrenolutin, in patients with severe heart failureJ L Rouleau, B Pitt, N S Dhalla, et al.

Pacing and Clinical Electrophysiology : PACE|May 30, 1998

Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: a prospective studyB Houltz, B Darpö, N Edvardsson, et al.

Journal of Cardiac Failure|May 9, 1998

Regional differences in the characteristics and treatment of patients participating in an international heart failure trial. The Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial InvestigatorsB M Massie, J G Cleland, P W Armstrong, et al.

European Journal of Heart Failure|August 21, 2001

Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practiceJ McMurray, A Cohen-Solal, R Dietz, et al.

Pageof 30

Showing results (241-250 of 297) with videos related to

Sort By:

Pageof 30

Journal of Internal Medicine. Supplement|January 1, 1991

Prehospital thrombolysis in suspected acute myocardial infarction: results from the TEAHAT StudyM Risenfors, G Gustavsson, L Ekström, et al.

Journal of Internal Medicine. Supplement|January 1, 1991

Mortality and morbidity 1 year after early thrombolysis in suspected AMI: results from the TEAHAT StudyJ Herlitz, M Dellborg, M Hartford, et al.

European Heart Journal|December 1, 1994

Elevated plasma endothelin concentrations in heart failure; an effect of angiotensin II?J M Good, P Nihoyannopoulos, M A Ghatei, et al.

Cardiovascular Research|December 23, 1998

Endothelin-1 has haemodynamic effects at pathophysiological concentrations in patients with left ventricular dysfunctionP J Cowburn, J G Cleland, J D McArthur, et al.

Journal of the American College of Cardiology|March 26, 1999

Endothelin B receptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunctionP J Cowburn, J G Cleland, J D McArthur, et al.

Cardiovascular Drugs and Therapy|October 12, 1999

Effects of the Ikr-blocker almokalant and predictors of conversion of chronic atrial tachyarrhythmias to sinus rhythm. A prospective studyB Houltz, B Darpö, K Swedberg, et al.

American Heart Journal|May 27, 2003

Prognostic importance of the oxidized product of catecholamines, adrenolutin, in patients with severe heart failureJ L Rouleau, B Pitt, N S Dhalla, et al.

Pacing and Clinical Electrophysiology : PACE|May 30, 1998

Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: a prospective studyB Houltz, B Darpö, N Edvardsson, et al.

Journal of Cardiac Failure|May 9, 1998

Regional differences in the characteristics and treatment of patients participating in an international heart failure trial. The Assessment of Treatment with Lisinopril and Survival (ATLAS) Trial InvestigatorsB M Massie, J G Cleland, P W Armstrong, et al.

European Journal of Heart Failure|August 21, 2001

Practical recommendations for the use of ACE inhibitors, beta-blockers and spironolactone in heart failure: putting guidelines into practiceJ McMurray, A Cohen-Solal, R Dietz, et al.

Pageof 30